Select Page

News

ONEpossible 2022

ONEpossible 2022

We are thrilled to let you know that this year, thanks to PRF’s many generous donors, our ONEpossible Campaign raised over $120,000!
With your generosity, children and young adults with Progeria can access the heart-strengthening, life-extending, FDA-approved drug Zokinvy, no matter where they live.

read more
Get PRF’s 2021 Annual Newsletter here!

Get PRF’s 2021 Annual Newsletter here!

Check out our newsletter to read about FDA approval for the first-ever treatment for Progeria, learn how the research we fund has made remarkable progress toward the cure through genetic and RNA therapies, and get the scoop on all the exciting milestones we’re celebrating right now.

read more
Another year of top Charity Navigator ratings!

Another year of top Charity Navigator ratings!

We’re thrilled to share that PRF has been awarded the highest 4-star Charity Navigator rating for our 8th straight year! CharityNavigator is the top evaluator of U.S.-based nonprofits, and this coveted 4-star rating is only awarded to 6% of the nonprofits evaluated....

read more
Exciting breakthroughs in RNA Therapeutics for Progeria!

Exciting breakthroughs in RNA Therapeutics for Progeria!

We’re thrilled to share the results from two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research. Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF’s Medical Director, Dr. Leslie Gordon.

read more